Market Analysis — RIVER HOSPITAL
NY market | 3 hospitals | HHI: 6,250 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
3
Hospitals in Market
232
Total Beds
$0.4B
Market Revenue
Concentrated
HHI: 6,250
None
Moat Rating (0/10)
#3
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantageweak
Switching Costslow
Market Share6.4%
Top 3 Concentration100.0%
Network Density1.29
Margin vs Market-5.5%
Bed Util vs Market-23.3%
What This Means
This hospital has a none moat — no moat — commoditized market position, pricing power limited. The NY market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 6,250).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full NY market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| SAMARITAN MEDICAL CENTER | 182 | $277M | 77.0% | 78.5% |
| CARTHAGE AREA HOSPITAL | 25 | $59M | 16.5% | 10.8% |
Regional Payer Mix
■ Medicare 32%■ Medicaid 6%■ Commercial 62%